Manganese-Induced Parkinsonism due to Ephedrone Abuse
Joint Authors
Sikk, Katrin
Haldre, Sulev
Taba, Pille
Aquilonius, Sten-Magnus
Source
Issue
Vol. 2011, Issue 2011 (31 Dec. 2011), pp.1-8, 8 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2011-01-18
Country of Publication
Egypt
No. of Pages
8
Main Subjects
Abstract EN
During recent years, a syndrome of hypokinesia, dysarthria, dystonia, and postural impairment, related to intravenous use of a “designer” psychostimulant derived from pseudoephedrine using potassium permanganate as the oxidant, has been observed in drug addicts in several countries in Eastern Europe with some cases also in Western countries.
A levodopa unresponsive Parkinsonian syndrome occurs within a few months of abusing the homemade drug mixture containing ephedrone (methcathinone) and manganese.
The development of this neurological syndrome has been attributed to toxic effects of manganese, but the role of the psychostimulant ephedrone is unclear.
This paper describes the clinical syndrome, results of neuroimaging, and therapeutic attempts.
American Psychological Association (APA)
Sikk, Katrin& Haldre, Sulev& Aquilonius, Sten-Magnus& Taba, Pille. 2011. Manganese-Induced Parkinsonism due to Ephedrone Abuse. Parkinson’s Disease،Vol. 2011, no. 2011, pp.1-8.
https://search.emarefa.net/detail/BIM-991118
Modern Language Association (MLA)
Sikk, Katrin…[et al.]. Manganese-Induced Parkinsonism due to Ephedrone Abuse. Parkinson’s Disease No. 2011 (2011), pp.1-8.
https://search.emarefa.net/detail/BIM-991118
American Medical Association (AMA)
Sikk, Katrin& Haldre, Sulev& Aquilonius, Sten-Magnus& Taba, Pille. Manganese-Induced Parkinsonism due to Ephedrone Abuse. Parkinson’s Disease. 2011. Vol. 2011, no. 2011, pp.1-8.
https://search.emarefa.net/detail/BIM-991118
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-991118